# Safety and Efficacy of R0.6C Vaccine

> **NCT04862416** · PHASE1 · COMPLETED · sponsor: **Radboud University Medical Center** · enrollment: 32 (actual)

## Conditions studied

- Malaria
- Malaria,Falciparum

## Interventions

- **BIOLOGICAL:** R0.6C transmission blocking vaccine

## Key facts

- **NCT ID:** NCT04862416
- **Lead sponsor:** Radboud University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-05-17
- **Primary completion:** 2022-06-29
- **Final completion:** 2022-06-29
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2025-03-05

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04862416

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04862416, "Safety and Efficacy of R0.6C Vaccine". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT04862416. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*